Grifols (GRFS) Tax Provisions (2010 - 2023)
Grifols' (GRFS) quarterly Tax Provisions came in at $46640.9 in Q4 2023, down 49.27% YoY from $91935.5 in Q4 2022, and down 49.27% on a QoQ basis from $91935.5 in Q4 2022.
Grifols (GRFS) Tax Provisions (2010 - 2023) Analysis & Trends
Grifols (GRFS) has 13 years of Tax Provisions data on file, last reported at $46640.9 in Q4 2023.
- Quarterly Tax Provisions fell 49.27% year-over-year to $46640.9 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$176.1 million (up 15.59% YoY) and the FY2025 annual result came in at $133.9 million, down 45.77% from the prior year.
- Tax Provisions fell to $46640.9 in Q4 2023, from $91935.5 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $91935.5 in Q4 2022 to a low of -$123.5 million in Q4 2019.
- A 4-year average of -$41.7 million and a median of -$32.5 million in 2019 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2019 — Tax Provisions grew 26.71% — and 2020, when it plunged 62.27%.
- Tracing GRFS's Tax Provisions over 4 years: stood at -$123.5 million in 2019, then surged by 57.34% to -$52.7 million in 2020, then surged by 100.17% to $91935.5 in 2022, then slumped by 49.27% to $46640.9 in 2023.
- The last three Tax Provisions figures came in at $46640.9 (Q4 2023), $91935.5 (Q4 2022), and -$52.7 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.01 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 291.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 266.99 Mn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 46,640.92 |
| Dec 31, 2022 | 91,935.51 |
| Mar 31, 2020 | -52.70 Mn |
| Dec 31, 2019 | -123.53 Mn |
| Mar 31, 2019 | -32.47 Mn |
| Dec 31, 2018 | -134.97 Mn |
| Jun 30, 2018 | 51.77 Mn |
| Mar 31, 2018 | -44.31 Mn |
| Dec 31, 2017 | -187.58 Mn |
| Jun 30, 2017 | 58.41 Mn |
| Mar 31, 2017 | -52.70 Mn |
| Dec 31, 2016 | 307.28 Mn |
| Sep 30, 2016 | 39.35 Mn |
| Jun 30, 2016 | 47.12 Mn |
| Dec 31, 2015 | 46.62 Mn |
| Sep 30, 2015 | 47.58 Mn |
| Jun 30, 2015 | 43.68 Mn |
| Mar 31, 2015 | -38.39 Mn |
| Jun 30, 2014 | 42,345.56 |
| Mar 31, 2014 | 48.97 Mn |